Featured Research

from universities, journals, and other organizations

Biomarker discovery may lead to reliable blood test for ectopic pregnancy

Date:
February 17, 2011
Source:
The Wistar Institute
Summary:
A long, urgent search for proteins in the blood of pregnant women that could be used in early diagnosis of ectopic pregnancy has resulted in discovery of biomarkers that seem to be specific enough to begin testing in clinical trials.

Scientists at The Wistar Institute and the University of Pennsylvania School of Medicine report the discovery of protein markers that could provide physicians with the first reliable blood test to predict ectopic pregnancies. Their findings are presented in the February 16 issue of the Journal of Proteome Research, currently available online. In a related small-scale study of clinical samples, published recently in the journal Fertility and Sterility, the researchers found that one of the proteins -- ADAM12 -- showed a nearly 97 percent correlation with ectopic pregnancy.

Ectopic pregnancies occur when a fertilized embryo fails to implant in the womb, often getting caught in the Fallopian tubes. As the embryo grows, the tube could rupture, which results in the loss of the embryo and threatens the life of the pregnant woman. Ectopic pregnancies occur in about one in 40 to 100 pregnancies, and it is a leading cause of death in the first trimester of pregnancy. There is no single proven blood test for ectopic pregnancy, and current diagnosis relies on the use of ultrasound.

"Here we describe a group of proteins that, with further refinement, could make a simple blood test for ectopic pregnancy," said David W. Speicher, Ph.D., professor and co-leader of Wistar's Molecular and Cellular Oncogenesis Program and director of Wistar's Center for Systems and Computational Biology. "This is also a proof-of-principle demonstration of a new method for the discovery of new blood-borne markers that may serve as diagnostic blood tests to detect or predict a variety of clinical conditions and diseases, from ectopic pregnancy to cancer."

According to Speicher, their study points to the power of proteomics -- the study of the sum total of proteins that the body is making at a given time -- in understanding the state of health or disease in people. Proteomics provides researchers an "unbiased" approach to the discovery of biomarkers, proteins in this case, which could be used to signal the presence of a particular clinical disorder or disease.

"Most biomarkers being used clinically today were first discovered by focused studies of proteins known to be associated with a disease, such as the prostate-specific antigen, PSA, test for prostate cancer," Speicher explained. "Proteomics is unbiased in the sense that we are not trying to confirm the presence of a known protein, we simply compare the entire protein profile of people in a particular clinical condition or disease state to the protein profile of people in a healthy state."

"Instead of a single biomarker, we can define a panel of such markers, creating a test that weighs the relative importance of individual proteins," Speicher said. "It makes for more sensitive, reliable tests."

In the present study, the Speicher laboratory compared the proteomic signature of blood samples taken from known cases of ectopic pregnancy with blood samples taken from women who experienced a normal pregnancy. They discovered about 70 candidate biomarkers that could signal ectopic pregnancy, which stringent statistical analysis whittled down to the 12 most promising biomarkers. While some of the proteins had previously known associations with ectopic pregnancies, the researchers found at least two, including ADAM12, which had never been previously associated with ectopic pregnancy.

Speicher and his team worked in collaboration with Kurt T. Barnhart, M.D., a professor of obstetrics and gynecology at the University of Pennsylvania School of Medicine. In a study recently published online by the journal Fertility and Sterility, Barnhart, Speicher and colleagues at Penn and two other urban academic medical centers reported on elevated ADAM12 levels in women seen in emergency rooms for bleeding resulting from an undiagnosed ectopic pregnancy.

The next step is to further confirm and validate the usefulness of their panel of biomarkers using additional patient samples in order to create a practical, reliable blood test for ectopic pregnancy, Speicher says. Among their goals is to identify particular isoforms -- that is, variations of a given protein -- that are most relevant to identifying ectopic pregnancy. Many proteins exhibit different isoforms in the body; that is, proteins that come from related genes, differences in processing the gene or modification of the protein in some way by cellular processes.

"The great power of biomarkers is to detect clinical disorders such as ecotopic pregnancy or diseases, such as cancer, early when it is often easiest to treat the patient," Speicher said. "Here we can envision a useful blood test that could, as part of routine early prenatal care, save the lives of many women."

Funding for this studied was provided through grants from the National Institutes of Health and the Philadelphia Health Care Trust. The lead author of the study is Lynn A. Beer, a research assistant in the Speicher laboratory. Co-authors also include Hsin-Yao Tang, Ph.D., a Wistar staff scientist, and Sira Sriswasdi, a Penn graduate student, both of whom are also members of the Speicher laboratory.


Story Source:

The above story is based on materials provided by The Wistar Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Lynn A. Beer, Hsin-Yao Tang, Sira Sriswasdi, Kurt T. Barnhart, David W. Speicher. Systematic Discovery of Ectopic Pregnancy Serum Biomarkers Using 3-D Protein Profiling Coupled with Label-free Quantitation. Journal of Proteome Research, 2011; 110107134921035 DOI: 10.1021/pr1008866

Cite This Page:

The Wistar Institute. "Biomarker discovery may lead to reliable blood test for ectopic pregnancy." ScienceDaily. ScienceDaily, 17 February 2011. <www.sciencedaily.com/releases/2011/02/110216124227.htm>.
The Wistar Institute. (2011, February 17). Biomarker discovery may lead to reliable blood test for ectopic pregnancy. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2011/02/110216124227.htm
The Wistar Institute. "Biomarker discovery may lead to reliable blood test for ectopic pregnancy." ScienceDaily. www.sciencedaily.com/releases/2011/02/110216124227.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins